SM
STEVEN MISTER
COUNCIL FOR RESPONSIBLE NUTRITION · WASHINGTON, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
3 agencies contacted
Activity
filings by quarter
Works on
Specific issues
All legislative proposals related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including H.R. 4794, the Dietary Supplements Access Act and S.3172, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products and foods for special dietary uses as qualified medical expenses.
H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory Product Listing for dietary supplements. General issues related to the dietary supplements industry.
Monitored the NDAA for any issues related to the dietary supplements industry.
H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to proposed FDA reorganization. General issues related to the dietary supplements industry.
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to nutritional access for underserved populations. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to proposed FDA reorganization. Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. General issues related to the dietary supplements industry.
Language concerning the appropriation of additional funding for FDA for research, policy evaluation, market surveillance, issuance of an enforcement discretion policy on hemp-derived Cannabidiol.